Advances in canine cardiology
|
|
- Godfrey Hart
- 5 years ago
- Views:
Transcription
1 Vet Times The website for the veterinary profession Advances in canine cardiology Author : PEDRO OLIVEIRA, ANTONIA MAVROPOULOU Categories : Vets Date : June 16, 2014 PEDRO OLIVEIRA DVM, DipECVIM-CA(Cardiology), MRCVS ANTONIA MAVROPOULOU DVM, MSc, PhD, Resident ECVIM-CA(Cardiology), MRCVS explain recent developments in two of the most researched areas in the field of dog heart studies, including approaches to diagnosis and treatment Summary The field of veterinary cardiology is continually expanding. Every year, numerous scientific articles are published as a result of the work of international study groups. The literature increases our knowledge and has a direct impact on the quality of the services we provide for our patients, although it makes it very difficult to keep up to date with this plethora of information. This discussion will focus on advances in two of the most researched areas in canine cardiology the study of chronic valvular heart disease (CVHD) and dilated cardiomyopathy (DCM). The most relevant aspects in the diagnosis and treatment of these diseases will be discussed in light of recent publications. Key words cardiology, dog, mitral valve disease, dilated cardiomyopathy EVERY year, numerous articles are published in scientific journals on several topics related 1 / 15
2 to veterinary medicine. This wealth of knowledge is very important to ensure our patients continue receiving the best care possible, at all times but it is, however, virtually impossible to keep up with every single new publication. The following discussion will focus on canine cardiology and highlight some of the most relevant advances published in regards to two of the most researched areas in this field. These are chronic valvular heart disease and dilated cardiomyopathy. Chronic valvular heart disease Chronic valvular heart disease (CVHD) also known as myxomatous mitral valve disease, or simply, mitral valve disease is the most common acquired heart disease in dogs1,2. This is a degenerative disease of the cardiac valves affecting particularly the mitral and to a lesser extent tricuspid valves. The valvular apparatus (for example, leaflets and chordae tendineae) becomes deformed and this results in several degrees of insufficiency (Figure 1). Clinical signs are not observed until heart failure develops. Symptoms include a reduction in exercise tolerance, which can be very difficult to appreciate; tachypnoea and dyspnoea secondary to pulmonary oedema; and, in later stages, syncope secondary to tachyarrhythmias or acute vasodilation. A cough is typically attributed to heart disease and is described in many textbooks as a sign of cardiogenic pulmonary oedema. However, a study showed congestive heart failure (CHF) was not significantly associated with a cough in CVHD. Dyspnoea and tachypnoea were consistent with pulmonary oedema, while a cough in the absence of other respiratory signs was an unlikely sign of CHF. The same study suggested the presence of airway disease and left atrial enlargement represented risk factors for coughing in dogs with CVHD3, although a previous smaller study had failed to show an association between left atrial enlargement and airway collapse in dogs with CVHD4. This suggests the cough observed in these dogs may be due to concomitant airway disease and is not a direct sign of heart disease or failure. It would explain why some dogs in heart failure do not cough at all, while others with well controlled CHF cough very frequently. This is very relevant since management of these cases should take this into account and we should think twice before starting treatment for heart failure merely based on whether a dog coughs. Diagnosis Diagnosis of CVHD is not particularly challenging. Identification of a characteristic murmur in a particular breed of a certain age is usually sufficient to raise suspicion. If every practitioner was 2 / 15
3 fortunate enough to have access to echocardiography, this disease could be diagnosed by anyone with a few basic echocardiography skills (Figure 1). The real challenge in these cases is often knowing when and how to treat. To help us with these decisions, a group of opinion leaders in veterinary cardiology proposed guidelines for classification and treatment5,6. The following disease stages were proposed: Stage A Dogs at high risk for developing CVHD (for example, cavalier King Charles spaniels) that at the present time do not have identifiable signs of the disease. Stage B Dogs with evidence of CVHD that have never developed clinical signs. Stage B dogs are further subdivided into two subclasses: Class B1 asymptomatic dogs without radiographic or echocardiographic evidence of cardiac remodelling (that is, dilation). Class B2 asymptomatic dogs with left-sided heart enlargement (Figures 1 and 2). Stage C Dogs with current or past clinical signs of left-sided heart failure (for example, dyspnoea) and/or low output symptoms (for example, exercise intolerance, syncope) secondary to CVHD. Stage D Dogs with clinical signs of CHF or low-output that are refractory to standard therapy (maximal recommended or tolerated furosemide dose associated with an angiotensin-converting enzyme [ACE] inhibitor and pimobendan). The course of CVHD is variable. Some dogs rapidly progress to the symptomatic stage, while others remain free of symptoms for several years. Treatment is only recommended when Stage C of the disease is reached and, therefore, much interest is put on timely recognition of the onset of clinical signs. For this purpose, several studies have focused on the use of biomarkers for the prediction of heart failure. The natriuretic peptides for example, the N-terminal pro-brain natriuretic peptide (NTproBNP) showed the most promise. Several studies have shown they increase in patients with heart disease, their concentration increases as the disease progresses, and they are predictive of 3 / 15
4 the onset of CHF and of mortality7,8,9. They may help to discriminate dogs with dyspnoea caused by CHF from dogs with primary respiratory disease10. However, it is important to remember they do not provide a definitive diagnosis and other diseases may lead to increased levels of natriuretic peptides (for example, kidney disease or pulmonary hypertension). Further investigation is always indicated, although a decision may be made on whether this should focus on heart disease or respiratory disease. Medical treatment We do not possess any drug capable of slowing valve degeneration. It is accepted that dogs in Stage A or Stage B Class B1 do not need treatment, but this is controversial for Stage B Class B2. Treatment is recommended for all dogs in Stage C and has to be tailored for each patient. Chronic treatment should always include furosemide, an ACE inhibitor and pimobendan5,6. Spironolactone may also be beneficial11. As disease progresses, the furosemide dosage is increased to effect although, in some patients, even dosages as high as 6mg/kg every eight hours are not enough to control CHF this is Stage D. Use of parenteral (subcutaneous) rather than oral furosemide is usually helpful in these cases. Spironolactone is used, if not already started, and the highest recommended dosages of ACE inhibitors and pimobendan are used. Torsemide a long-acting loop diuretic that is 10 times as potent as furosemide is another option in these cases12. Sildenafil may be used in cases with evidence of pulmonary hypertension. Cough suppressants and bronchodilators can also be used in both Stage C and Stage D5,6. Surgical repair of mitral valves Perhaps the most exciting news in recent times is reports of success with surgical mitral repair from a Japanese group. A few publications described the technique and results available so far13,14,15. In human medicine, mitral valve repair or replacement is common for treatment of degenerative valve disease. This is very challenging and requires a great deal of experience with cardiopulmonary bypass, full awareness and understanding of how the mitral valve apparatus works and, of course, outstanding surgical skills. Under cardiopulmonary bypass, an incision is made in the left atrial wall to access the mitral valve. A suture or a soft prosthetic ring is placed around the mitral annulus to reduce annular size and the chordae tendineae are replaced with expanded polytetrafluoroethylene as necessary14. 4 / 15
5 The results of this technique in 48 cases have been reported13. The survival rate at discharge was 94 per cent (45 out of 48) with significant reductions in mitral regurgitation and cardiac size. These dogs were alive and well at least five months after surgery. Of the three dogs that did not survive, one died as a result of bleeding during recovery from anaesthesia and the other two died of thrombosis within eight days of the surgery13. Long-term outcome has been reported in three cases15. One died after two years due to partial circumferential suture detachment, resulting in severe mitral regurgitation and CHF. The other two cases survived for more than five years, although mitral valve stenosis was present in one. The replaced chordae did not rupture in any dog. Hopefully, with time, these procedures will become more available and bring new hope for our patients. Dilated cardiomyopathy Dilated cardiomyopathy (DCM) is a disease of the cardiac muscle characterised by a progressive loss of contractile strength and consequent dilation of the ventricular chambers. The disease is almost certainly genetic in origin in most dogs and is more prevalent in some breeds such as the Dobermann pinscher, which is the typical example. The prevalence of the disease differs between countries and depends on the gene pool in a particular region16. A scientific paper reported how the prevalence of DCM in great Danes in the UK is higher than previously reported17. Other affected breeds include boxers, Labradors and golden retrievers, Newfoundlands, St Bernards, and English and American cocker spaniels16. The disease progresses through an occult to an overt stage. Three distinct phases have been described in the Dobermann pinscher. Dogs in Stage I are asymptomatic and evidence of morphological or electrical abnormalities is not detectable. Dogs in Stage II (occult phase) are also asymptomatic, but electrical abnormalities, morphological changes or both are present. Most of these dogs eventually progress to Stage III (overt stage) in which clinical signs such as syncope or CHF occur. Long-term survival is poor at this stage and it is not uncommon for sudden death to be the first and only clinical sign of the disease. For this reason, great effort is made to identify these dogs while still in the occult stage. Diagnosis of occult DCM Diagnosis of DCM in the occult stage is very challenging. It involves either detection of ventricular arrhythmias on an electrocardiogram (ECG; usually a 24-hour ambulatory ECG Holter), detection of left ventricular enlargement due to systolic dysfunction on echocardiography, or both (Figures 3 and 5 / 15
6 4 ). This requires referral to a trained individual with access to the necessary facilities. Additionally, dogs can remain in this stage for a few years and the incidence increases with age. For this reason, yearly screening is recommended from an age as low as two years in the case of Dobermann pinschers. This translates into significant cost and owner commitment throughout the dog s life. A study involving 155 Dobermann pinschers suggested the use of NT-proBNP could be useful for detection of occult DCM, particularly if combined with information from a Holter monitor18. According to the results, an NT-proBNP value of more than 457pmol/L would only allow identification of 69.9 per cent of the affected dogs. However, if combined with the presence of greater than 50 ventricular premature complexes (VPCs) in 24 hours during Holter monitoring, 94.6 per cent of these dogs would be identified. A previous report involving 328 Dobermann pinschers indicated that asymptomatic dogs with Holter evidence of arrhythmias (greater than 100 VPCs over 24h) and no abnormalities on echocardiography had increased NT-proBNP levels, while apparently healthy dogs that subsequently developed DCM within 1.5 years had higher NT-proBNP values than control dogs19. Based on this information it would not be wrong to assume that in this breed, performing these two tests once yearly might be a good way to start, followed by echocardiography in all suspected cases. Further studies are required to determine the value of these diagnostic tests in the preclinical phase of the disease in other affected breeds. Treatment in overt stage Treatment of DCM aims to reduce clinical signs and increase survival and quality of life. This includes use of diuretics, ACE inhibitors, inotropic agents (for example, pimobendan) and antiarrhythmic drugs. Treatment in occult stage A very important question when managing any disease is whether starting treatment with a certain drug during the asymptomatic stage will result in a delay of onset of clinical signs and better survival. A study provided some insight into the use of pimobendan in these cases20. Pimobendan was given to 39 Dobermann pinschers with occult DCM, while another 37 received a placebo. The median time to either sudden death or development of CHF was significantly longer (nine months) for dogs receiving pimobendan than for dogs receiving placebo. Additionally, no evidence of increased risk of proarrhythmia or sudden death was noticed with pimobendan. 6 / 15
7 Based on the results of this study, pimobendan appears to be safe and effective in prolonging time to onset of CHF and sudden death in Dobermanns with preclinical DCM20. It is important to point out all these dogs had signs of left ventricular enlargement identified on echocardiography and that, before starting this drug in a dog with suspicion of DCM, a full investigation is recommended, including Holter monitoring and echocardiography. The results of this study only indicate pimobendan might prolong time to CHF or sudden death, but do not suggest it prevents their occurrence. Additionally, this study only included Dobermann pinschers and therefore extrapolation to other breeds is not possible. Please note some drugs mentioned in this article are not licensed in dogs and are used under the cascade. References 1. Buchanan J (1992). Causes and prevalence of cardiovascular disease. In Kirk R and Bonagura J (eds), Kirk s Current Veterinary Therapy XI, W B Saunders, Philadelphia: Borgarelli M and Buchanan J (2012). Historical review, epidemiology and natural history of degenerative mitral valve disease, Journal of Veterinary Cardiology 14(1): Ferasin L, Crews L, Biller D S, Lamb K E and Borgarelli M (2013). Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease, Journal of Veterinary Internal Medicine 27(2): Singh M K, Johnson L R, Kittleson M D and Pollard R E (2012). Bronchomalacia in dogs with myxomatous mitral valve degeneration, Journal of Veterinary Internal Medicine 26(2): Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Häggström J, Hamlin R, Keene B, Luis-Fuentes V and Stepien R (2009). Guidelines for the diagnosis and treatment of canine chronic valvular heart disease, Journal of Veterinary Internal Medicine 23(6): 1,142-1, Atkins C E and Häggström J (2012). Pharmacologic management of myxomatous mitral valve disease in dogs, Journal of Veterinary Cardiology 14(1): Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, Arisawa K, Kurita T, Nunokawa K, Hirakawa A, Tanaka S and Hirose H (2009). Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency, The Journal of Veterinary Medical Science 71(1): Moonarmart W, Boswood A, Luis Fuentes V, Brodbelt D, Souttar K and Elliott J (2010). N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease, Journal of Small Animal Practice 51(2): Chetboul V, Serres F, Tissier R, Lefebvre H P, Sampedrano C C, Gouni V, Poujol L, Hawa G and Pouchelon J (2009). Association of plasma N-terminal pro-b-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with 7 / 15
8 asymptomatic degenerative mitral valve disease, Journal of Veterinary Internal Medicine 23(5): Fine D M, DeClue A E and Reinero C R (2008). Evaluation of circulating amino terminalpro-b-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease, Journal of the American Veterinary Medical Association 232(11): 1,674-1, Bernay F, Bland J M, Häggström J, Baduel L, Combes B, Lopez A and Kaltsatos V (2010). Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease, Journal of Veterinary Internal Medicine 24(2): Oyama M A, Peddle G D, Reynolds C A and Singletary G E (2011). Use of the loop diuretic torsemide in three dogs with advanced heart failure, Journal of Veterinary Cardiology 13(4): Uechi M, Mizukoshi T, Mizuno T, Mizuno M, Harada K, Ebisawa T, Takeuchi J, Sawada T, Uchida S, Shinoda A, Kasuya A, Endo M, Nishida M, Kono S, Fujiwara M and Nakamura T (2012). Mitral valve repair under cardiopulmonary bypass in small-breed dogs: 48 cases ( ), Journal of the American Veterinary Medical Association 240(10): 1,194-1, Uechi M (2012). Mitral valve repair in dogs, Journal of Veterinary Cardiology 14(1): Mizuno T, Mizukoshi T and Uechi M (2013). Long-term outcome in dogs undergoing mitral valve repair with suture annuloplasty and chordae tendinae replacement, Journal of Small Animal Practice 54(2): Kittleson M and Kienle R (1998). Primary myocardial disease. In Kittleson M and Kienle R (eds), Small Animal Cardiovascular Medicine, Mosby. 17. Stephenson H M, Fonfara S, Lopez-Alvarez J, Cripps P and Dukes-McEwan J (2012). Screening for dilated cardiomyopathy in great Danes in the United Kingdom, Journal of Veterinary Internal Medicine 26(5): 1,140-1, Singletary G E, Morris N A, Lynne O Sullivan M, Gordon S G and Oyama M A (2012). Prospective evaluation of NT-proBNP assay to detect occult dilated cardiomyopathy and predict survival in Dobermann pinschers, Journal of Veterinary Internal Medicine 26(6): 1,330-1, Wess G, Butz V, Mahling M and Hartmann K (2011). Evaluation of N-terminal pro-btype natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Dobermann pinschers, American Journal of Veterinary Research 72(5): Summerfield N J, Boswood A, O Grady M R, Gordon S G, Dukes- McEwan J, Oyama M A, Smith S, Patteson M, French A T, Culshaw G J, Braz-Ruivo L, Estrada A, O Sullivan M L, Loureiro J, Willis R and Watson P (2012). Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Dobermann pinschers with preclinical dilated cardiomyopathy (the PROTECT study), Journal of Veterinary Internal Medicine 26(6): 1,337-1, / 15
9 9 / 15
10 10 / 15
11 Figure 1. Chronic valvular disease echocardiographic images illustrating mitral valve thickening and prolapse (1a and 1b) causing regurgitation evidence on colour flow Doppler (1c). Figure 2. Chronic valvular disease chest radiographs illustrating cardiomegaly. 11 / 15
12 12 / 15
13 13 / 15
14 Figure 3. Dilated cardiomyopathy echocardiographic images illustrating marked left ventricular enlargement (3a and 3b) and poor contractility evidence on M-mode (3c). Figure 4. Dilated cardiomyopathy electrocardiogram showing frequent ventricular premature complexes (4a) and ventricular tachycardia (4b). 14 / 15
15 15 / 15 Powered by TCPDF (
ADVANCES IN MITRAL VALVE DISEASE
Vet Times The website for the veterinary profession https://www.vettimes.co.uk ADVANCES IN MITRAL VALVE DISEASE Author : Gemma Hopkins Categories : Vets Date : June 1, 2009 Gemma Hopkins relates an informative
More informationCANINE ACQUIRED HEART DISEASE: ADVANCES IN MEDICAL TREATMENT
Vet Times The website for the veterinary profession https://www.vettimes.co.uk CANINE ACQUIRED HEART DISEASE: ADVANCES IN MEDICAL TREATMENT Author : Emily Dutton, Simon Swift Categories : Vets Date : July
More informationDiagnosis of heart failure in dogs with mitral valve disease
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Diagnosis of heart failure in dogs with mitral valve disease Author : PHILLIP SPEER Categories : Vets Date : March 31, 2014
More informationSarah J. Miller, DVM, Diplomate ACVIM (Cardiology) Degenerative Valvular Disease What s New?
Sarah J. Miller, DVM, Diplomate ACVIM (Cardiology) Degenerative Valvular Disease What s New? Chronic degenerative valvular disease is the most common cardiovascular disease in small animals, and is also
More informationAbout the Cardiac Education Group (CEG) The CEG Mission. The CEG promotes and facilitates:
About the Cardiac Education Group (CEG) The Cardiac Education Group is a group of board certified veterinary cardiologists from both academia and private practice that offers independent recommendations
More informationAtrioventricular Valve Endocardiosis Basics
Atrioventricular Valve Endocardiosis Basics OVERVIEW Atrioventricular valve refers to the heart valves between the top chamber (known as the atrium ) and the bottom chamber (known as the ventricle ) of
More informationFinding a Consensus on. Cardiology) Canine CVHD ACVIM & ECVIM
H o w I Tre a t Peer Reviewed C A R D I O L O G Y Clarke Atkins, DVM, Diplomate ACVIM (Internal Medicine & Cardiology), North Carolina State University Finding a Consensus on Canine CVHD Canine chronic
More information1 Michele Borgarelli
# Michele Borgarelli 1 1 DVM, PhD, DipECVIM-CA (Cardiology) Associate Professor Virginia- Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA MAKING TOMORROW HAPPEN TODAY
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress AN APPROACH TO ASYMPTOMATIC ACQUIRED HEART DISEASE IN DOGS Clarke E. Atkins, DVM Diplomate, ACVIM (Internal Medicine
More informationBreed specificities of Canine Dilated Cardiomyopathy Dr. Gerhard Wess
Breed specificities of Canine Dilated Cardiomyopathy Dr. Gerhard Wess Diplomate ACVIM (Cardiology) Diplomate ECVIM-CA (Cardiology) Diplomate ECVIM-CA (Internal Medicine) INTRODUCTION Inherent disease of
More informationCardiology made easy. Dr. Markus Killich DipACVIM (Cardiology) DipECVIM-CA (Cardiology)
Cardiology made easy Dr. Markus Killich DipACVIM (Cardiology) DipECVIM-CA (Cardiology) www.kardiokonsult.de questions Does a patient have heart disease? What kind of heart disease does it have? What is
More informationMITRAL VALVE DISEASE IN CAVALIER KING CHARLES SPANIELS. Carroll Loyer, DVM, DACVIM
MITRAL VALVE DISEASE IN CAVALIER KING CHARLES SPANIELS Carroll Loyer, DVM, DACVIM CAVIEPALOOZA!! MITRAL INSUFFICIENCY mitral regurgitation (MR) chronic degenerative mitral valve disease (CVD) myxomatous
More informationUse of cardiac medications in congestive heart failure cases
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Use of cardiac medications in congestive heart failure cases Author : Antonia Mavropoulou Categories : Companion animal, Vets
More informationAbstract Clinical and paraclinical studies on myocardial and endocardial diseases in dog
Abstract The doctoral thesis entitled Clinical and paraclinical studies on myocardial and endocardial diseases in dog was motivated by the study of the most frequent cardiopathies in dogs, which involves
More informationHEART MURMURS: DECIPHERING THEIR CAUSE AND SIGNIFICANCE
Vet Times The website for the veterinary profession https://www.vettimes.co.uk HEART MURMURS: DECIPHERING THEIR CAUSE AND SIGNIFICANCE Author : Pedro Oliveira Categories : Vets Date : May 27, 2013 PEDRO
More informationFORUM VET. October 2012 No. 2. New Therapeutic Ration Formulation Evaluation for use in dogs with Degenerative Mitral Valve disease: Aspects
FORUM VET October 2012 No. 2 New Therapeutic Ration Formulation Evaluation for use in dogs with Degenerative Mitral Valve disease: Aspects Clinical, Laboratory and Echocardiographic CARDIAC CA Technical
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers MANAGEMENT
More informationADVANCES IN UNDERSTANDING OF CANINE DILATED CARDIOMYOPATHY
Vet Times The website for the veterinary profession https://www.vettimes.co.uk ADVANCES IN UNDERSTANDING OF CANINE DILATED CARDIOMYOPATHY Author : SIMON SWIFT Categories : Vets Date : December 21, 2009
More informationCutting Edge Cardiology
Peer Reviewed Cutting Edge Cardiology Five State-of-the-Art Developments Ashley B. Saunders, DVM, Diplomate ACVIM (Cardiology) Texas A&M University Veterinary practitioners strive to provide patients and
More information6523 California Ave SW STE 320 Seattle, Wa /13/2017
6523 California Ave SW STE 320 Seattle, Wa 98136 info@dobermanhealth.org 11/13/2017 The Doberman Pinscher Health Foundation is happy to inform you that we are funding the research titled Spontaneous day-to-day
More informationDilated Cardiomyopathy in Dogs
Dilated Cardiomyopathy in Dogs (a Type of Heart-Muscle Disease) Basics OVERVIEW The heart of the dog is composed of four chambers; the top two chambers are the left and right atria and the bottom two chambers
More informationCANINE CONGESTIVE HEART FAILURE
Vet Times The website for the veterinary profession https://www.vettimes.co.uk CANINE CONGESTIVE HEART FAILURE Author : Simon Swift Categories : Vets Date : March 30, 2009 Simon Swift explains how quick,
More informationHEART MUSCLE DISEASE IN DOGS
Vet Times The website for the veterinary profession https://www.vettimes.co.uk HEART MUSCLE DISEASE IN DOGS Author : Simon Swift Categories : Vets Date : January 21, 2013 SIMON SWIFT considers the potential
More informationAN APPROACH TO ASYMPTOMATIC ACQUIRED HEART DISEASE IN DOGS AND CATS
AN APPROACH TO ASYMPTOMATIC ACQUIRED HEART DISEASE IN DOGS AND CATS Clarke E. Atkins, DVM Diplomate, ACVIM (Internal Medicine & Cardiology) Jane Lewis Seaks Distinguished Professor Emeritus Department
More informationIn this Issue. EPIC change in the way to manage Mitral Valve Disease in Dogs
In this Issue COVER EPIC change in the way to manage Mitral Valve Disease in Dogs An EPIC change in the way to manage mitral valve disease in dogs. Page 4 Opening October New Columbia, MD Location For
More informationAn informational newsletter
Pacific Tide An informational newsletter Pacific Veterinary Specialists & Emergency Service 1980 41 st Avenue Capitola, CA 95010 Specialty 831-476-2584 ~Emergency 831-476-0667 January 2014 Volume 1, Issue
More informationCanine Degenerative Myxomatous Mitral Valve Disease: Natural History, Clinical Presentation and Therapy
Canine Degenerative Myxomatous Mitral Valve Disease: Natural History, Clinical Presentation and Therapy Michele Borgarelli, DMV, PhD a, *, Jens Haggstrom, DVM, PhD b KEYWORDS Canine Mitral valve Myxomatous
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationMitral Valve Disease (MVD)
Mitral Valve Disease (MVD) What is the mitral valve? The heart contains 4 valves within it. Each valve is present to allow unidirectional flow and to prevent flow backwards. The mitral valve is the valve
More informationDIAGNOSING HEART FAILURE IN DOGS
Vet Times The website for the veterinary profession https://www.vettimes.co.uk DIAGNOSING HEART FAILURE IN DOGS Author : Mike Martin Categories : Vets Date : November 7, 2011 Mike Martin offers advice
More informationAtrioventricular Valve Dysplasia
Atrioventricular Valve Dysplasia How does the heart work? The heart is the organ responsible for pumping blood to and from all tissues of the body. The heart is divided into right and left sides. The job
More informationElectrocardiographic changes in chronic valvular disease and dilated cardiomyopathy in dog
Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article Electrocardiographic changes in chronic valvular disease and dilated cardiomyopathy in dog Radu A.
More informationIntroduction. Materials and Methods. Andrea C. Vollmar, DVM
Use of Echocardiography in the Diagnosis of Dilated Cardiomyopathy in Irish Wolfhounds The purpose of this study was to compare the echocardiographic features of Irish wolfhounds with clinically inapparent
More informationRight-Sided Congestive Heart Failure Basics
Right-Sided Congestive Heart Failure Basics OVERVIEW Failure of the right side of the heart to pump blood at a sufficient rate to meet the needs of the body or to prevent blood from pooling within the
More informationDilated cardiomyopathy (DCM) continues to be an
J Vet Intern Med 2009;23:977 983 Efficacy of Benazepril Hydrochloride to Delay the Progression of Occult Dilated Cardiomyopathy in Doberman Pinschers M.R. O Grady, M.L. O Sullivan, S.L. Minors, and R.
More informationDilated cardiomyopathy (DCM) is the most common
J Vet Intern Med 2012 Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study) N.J. Summerfield,
More informationDiagnosis is complicated
Peer reviewed Cardiac Blood Tests in Cats Another Tool for Detection of Heart Disease Mark A. Oyama, DVM, Diplomate ACVIM (Cardiology) Detection of asymptomatic (occult) heart disease in cats is challenging.
More informationBOXER CARDIOMYOPATHY
BOXER CARDIOMYOPATHY by: Wendy Wallner, DVM What is Boxer cardiomyopathy? Boxer cardiomyopathy as we know it consists primarily of an electrical conduction disorder which causes the heart to beat erratically
More informationCanine cardiology: conditions, causes, advances and care
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Canine cardiology: conditions, causes, advances and care Author : Samantha Frogley Categories : RVNs Date : May 1, 2014 Samantha
More informationBoxer dogs are predisposed to congenital cardiac
J Vet Intern Med 2014;28:116 122 Simpson s Method of Discs for Measurement of Echocardiographic End-Diastolic and End-Systolic Left Ventricular Volumes: Breed-Specific Reference Ranges in Boxer Dogs P.
More informationSimplifying mitral valve disease diagnostics
DIAGNOSIS Simplifying mitral valve disease diagnostics Nuala Summerfield Myxomatous mitral valve disease (MMVD) in dogs is a slowly progressive disease. Until recently, focus was aimed at the symptomatic
More informationHeart Disease in Dogs: An Overview
Heart Disease in Dogs: An Overview Heart disease in dogs is a commonly diagnosed condition. A dog s heart, lungs, and blood vessels combine to form his circulatory system. The heart is the central player
More informationPulmonic Stenosis. How does the heart work?
Pulmonic Stenosis How does the heart work? The heart is the organ responsible for pumping blood to and from all tissues of the body. The heart is divided into right and left sides. The job of the right
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationMYXOMATOUS MITRAL VALVE DISEASE IN A SHIH TZU DOG SUMMARY
Case Reports MYXOMATOUS MITRAL VALVE DISEASE IN A SHIH TZU DOG Y.B. Teoh and K.H. Khor* Faculty of Veterinary Medicine, University Putra Malaysia, UPM Serdang, Selangor, Malaysia SUMMARY An 11-year-old
More informationDogs live even longer on Vetmedin
Dogs live even longer on Vetmedin Use Vetmedin first. Because every day counts Makes life worth living QUEST: Largest canine cardio The QUality of Life and Extension of Survival Time (QUEST) trial is the
More informationClinical Assessment of Heart Disease Using Cardiac Biomerker in Dogs and Cats
44 1 19 (2011) 0348628 351 2010 12 25 Clinical Assessment of Heart Disease Using Cardiac Biomerker in Dogs and Cats Yasutomo HORI Department of Small Animal Internal Medicine, School of Veterinary Medicine,
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationClinical study into prognostic value of NT-proBNP in feline heart disease
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Clinical study into prognostic value of NT-proBNP in feline heart disease Author : Martin Atkinson Categories : Vets Date
More informationCardiomyopathy and Less Common Canine Heart Disease
Cardiomyopathy and Less Common Canine Heart Disease John E. Rush, DVM, MS, DACVIM (Cardiology), ACVECC Cummings School of Veterinary Medicine at Tufts University Dilated cardiomyopathy (DCM) is the second
More informationSaluki heart pathology study
Heart conditions by MaryDee Sist, DVM Originally published in Baraka Book, Autumn-Winter 2001 For the last decade I have been involved in Saluki heart research. Ouroriginalgoalwastoexaminethe incidence
More informationMurmur diagnosis in cats. Your pet has a murmur! Meg Sleeper VMD, DACVIM (cardiology) Gainesville, FL. Reasons to work up the murmur in a cat
Murmur diagnosis in cats Your pet has a murmur! Meg Sleeper VMD, DACVIM (cardiology) Gainesville, FL Heart disease diagnosis in cats and kittens in general is challenging because: Approximately ½ of systolic
More informationSeptal Defects. How does the heart work?
Septal Defects How does the heart work? The heart is the organ responsible for pumping blood to and from all tissues of the body. The heart is divided into right and left sides. The job of the right side
More informationThe unique combination of benazepril and spironolactone
The unique combination of benazepril and spironolactone ANGIOT Angiotensin II and aldosterone Heart failure causes activation of the RAAS System and the production of angiotensin ll and aldosterone 1 Heart
More informationNIGERIAN VETERINARY JOURNAL
NIGERIAN VETERINARY JOURNAL ISSN 0331-3026 Nig. Vet. J., December 2015 Vol. 36 (4): 1283-1287. ORIGINAL ARTICLE Preliminary Assessment of Vertebral Heart Score of the Nigerian Mongrel Dog Olatunji-Akioye,
More informationUpdate on mitral valve disease in 2018
Update on mitral valve disease in 2018 Rebecca L. Stepien DVM, MS, DACVIM (Cardiology) University of Wisconsin School of Veterinary Medicine Madison, WI USA 1. What is this disease? (endocardiosis, acquired
More informationCritical appraisal Gelzer et al., 2009 Randomized controlled trial questions. Introduction. Are the aims clearly stated? Methods
Critical appraisal Gelzer et al., 2009 Randomized controlled trial questions Introduction Are the aims clearly stated? Methods Is the study design suitable for the aims? Which population was studied?.
More informationLecture outline. Electrical properties of the heart. Automaticity. Excitability. Refractoriness. The ABCs of ECGs Back to Basics Part I
Lecture outline The ABCs of ECGs Back to Basics Part I Meg Sleeper VMD, DACVIM (cardiology) University of Florida Veterinary School Electrical properties of the heart Action potentials Normal intracardiac
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetmedin 10 mg chewable tablets for dogs. (AT, BG, CY, CZ, EE, EL, HU, IT, LV, LT, PL, RO, SI, SK, ES, LI, PT, BE, LU, NL,
More informationPatent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA) How does the heart work? The heart is the organ responsible for pumping blood to and from all tissues of the body. The heart is divided into right and left sides. The job
More informationCoughing is an important physiological function
J Vet Intern Med 2013;27:286 292 Risk Factors for Coughing in Dogs with Naturally Acquired Myxomatous Mitral Valve Disease L. Ferasin, L. Crews, D.S. Biller, K.E. Lamb, and M. Borgarelli Background: Cough
More informationClinical Indications for Echocardiography
Clinical Indications for Echocardiography Echocardiography is widely utilised and potential applications are increasing with advances in technology. The aim of this document is two-fold: 1) To define clinical
More information7 avenue du Général de Gaulle, Maisons-Alfort Cedex, France b Pharmacy-Toxicology Unit of Alfort, National Veterinary School of Alfort,
Journal of Veterinary Cardiology (2006) 8, 11e18 www.elsevier.com/locate/jvc Retrospective study of 942 small-sized dogs: Prevalence of left apical systolic heart murmur and left-sided heart failure, critical
More informationI mary myocardial disorder characterized by left
Idiopathic Dilated Cardiomyopathy in Dogs: Survival and Prognostic Indicators Eric Monnet, E. Christopher Orton, Mo Salman, and June Boon To further define the prognosis and identify clinical findings
More information1. Definition/Overview
VCAwestlaspecialty.com VCA West Los Angeles recently performed closure of a patent ductus arteriosus via percutaneous transarterial embolization with an Amplatz canine ductal occluder on a female, four-month-old
More informationClinical assessment of heart disease in dogs has traditionally
SMALL ANIMALS Clinical utility of serum N-terminal pro-b-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity Mark A. Oyama, dvm, dacvim; Philip
More informationInternational Congress of the Italian Association of Companion Animal Veterinarians
Close this window to return to IVIS www.ivis.org International Congress of the Italian Association of Companion Animal Veterinarians 28-30 May, 2010 Rimini, Italy Next Congress : SCIVAC International Congress
More informationDilated cardiomyopathy (DCM) is an important
J Vet Intern Med 2010;24:1069 1076 Use of Simpson s Method of Disc to Detect Early Echocardiographic Changes in Doberman Pinschers with Dilated Cardiomyopathy G. Wess, J. Mäurer, J. Simak, and K. Hartmann
More informationSTANDARDS of CARE. Canine idiopathic dilated cardiomyopathy (DCM) is a primary EMERGENCY AND CRITICAL CARE MEDICINE CANINE DILATED CARDIOMYOPATHY
Visit us at www.vetlearn.com APRIL 2003 VOL 5.3 STANDARDS of CARE EMERGENCY AND CRITICAL CARE MEDICINE FROM THE PUBLISHER OF COMPENDIUM CANINE DILATED CARDIOMYOPATHY Bruce G. Kornreich, DVM, DACVIM (Cardiology)
More informationNorth Carolina State University, Raleigh NC, USA 2 Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences
CLASSIFICATION AND ADVANCES IN THE MANAGEMENT OF CANINE HEART FAILURE Clarke E. Atkins 1, DVM, DACVIM (Internal Medicine & Cardiology) and Marisa K. Ames 2, DVM, DACVIM (Cardiology) 1 Department of Clinical
More informationWhich Drugs Treat Ventricular Arrhythmias in Dogs & Cats?
Rx SOLUTIONS PEER REVIEWED Which Drugs Treat Ventricular Arrhythmias in Dogs & Cats? Amara Estrada, DVM, DACVIM (Cardiology) University of Florida 2015 Kip Carter, MS, CMI Profile Most antiarrhythmic agents
More informationInternational Journal of Science, Environment and Technology, Vol. 5, No 6, 2016,
International Journal of Science, Environment and Technology, Vol. 5, No 6, 2016, 4612 4617 ISSN 2278-3687 (O) 2277-663X (P) STUDY ON PATHOMORPHOLOGICAL CHANGES IN 21 CASES OF CANINE DILATED CARDIOMYOPATHY
More informationStaging and Treating Patients with Heart Failure Henry Green, III, DVM, DACVIM Purdue University West Lafayette, IN
Staging and Treating Patients with Heart Failure Henry Green, III, DVM, DACVIM Purdue University West Lafayette, IN There are many different diseases that can cause signs of congestive heart failure(chf)
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetmedin 5 mg chewable tablets for dogs (AT, BG, CY, CZ, EE, EL, HU, LV, LT, PL, RO, SI, SK, ES, LI, PT, BE, LU, NL, FR,
More informationRetrospective analysis of co-occurrence of congenital aortic stenosis and pulmonary artery stenosis in dogs
Polish Journal of Veterinary Sciences Vol. 18, No. 4 (2015), 841 845 DOI 10.1515/pjvs-2015-0109 Original article Retrospective analysis of co-occurrence of congenital aortic stenosis and pulmonary artery
More informationNatriuretic peptides (NPs) are used as indicators of
J Vet Intern Med 2014;28:451 457 Breed Differences in Natriuretic Peptides in Healthy Dogs K. Sj ostrand, G. Wess, I. Ljungvall, J. H aggstr om, A-C. Merveille, M. Wiberg, V. Gouni, J. Lundgren Willesen,
More informationCan ventricular function be assessed by echocardiography in chronic canine mitral valve disease?
REVIEW Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? Mitral regurgitation (MR) related to chronic degenerative valvular disease is the most important
More informationBenazepril - Spironolactone 10 years of research
Benazepril - Spironolactone 10 years of research What s new with aldosterone? The story of spironolactone in human and veterinary cardiology Benazepril - Spironolactone 10 years of research Authors Clarke
More information6/14/17. Recognizing and Treating LifeThreatening Arrhythmias. Overview. Why do an ECG?
6/14/17 Recognizing and Treating LifeThreatening Arrhythmias Sandy Tou, DVM DACVIM (Cardiology & Internal Medicine) Raleigh, NC Overview Brief overview of basic ECG principles ECG diagnosis & treatment
More informationAngiotensin-converting enzyme inhibitors (ACEIs)
J Vet Intern Med 2008;22:905 914 Effect of Benazepril on Survival and Cardiac Events in Dogs with Asymptomatic Mitral Valve Disease: A Retrospective Study of 141 Cases J.-L. Pouchelon, N. Jamet, V. Gouni,
More informationPatent Ductus Arteriosus
Patent Ductus Arteriosus (Type of Heart Birth Defect) Basics OVERVIEW Patent refers to open ; ductus arteriosus is a blood vessel between the aorta (main artery of the body) and the pulmonary artery (main
More informationAuscultation screening (listening with a stethoscope) at shows for murmurs which could be associated with aortic stenosis has been underway for some
A report on cardiac examinations performed at the Saluki or Gazelle Hound Club Championship show on 1/11/2009 S.E. Brownlie PhD BVM&S MRCVS Cert SAC Kileeekie, Crosshill, Maybole, Ayrshire KA19 7PY My
More informationIncidentally-detected heart murmurs in dogs and cats: executive summary 2015
Incidentally-detected heart murmurs in dogs and cats: executive summary 2015 E Côté, NJ Edwards, SJ Ettinger, VL Fuentes, KA MacDonald, BA Scansen, DD Sisson, JA Abbott.* An incidentally-detected heart
More informationProceedings of the Southern European Veterinary Conference - SEVC -
www.ivis.org Proceedings of the Southern European Veterinary Conference - SEVC - Sep. 29-Oct. 2, 2011, Barcelona, Spain Next SEVC Conference: Oct. 18-21, 2012 - Barcelona, Spain Reprinted in the IVIS website
More informationPractical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em
Practical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em Introduction The use of ultrasound in private veterinary practice is continuing to grow. The popularity of
More informationTricuspid and Pulmonic Valve Disease
Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the
More informationVentricular Tachycardia Basics
Ventricular Tachycardia Basics OVERVIEW Ventricular refers to the ventricles of the heart; tachycardia is the medical term for rapid heart rate The heart of the dog or cat is composed of four chambers;
More informationClinical significance of cardiac murmurs: Get the sound and rhythm!
Clinical significance of cardiac murmurs: Get the sound and rhythm! Prof. dr. Gunther van Loon, DVM, PhD, Ass Member ECVDI, Dip ECEIM Dept. of Large Animal Internal Medicine Ghent University, Belgium Murmurs
More informationAtrial Fibrillaton. Key: RA: right atrium RV: right ventricle PA: pulmonic artery LA: left atrium LV: left ventricle AO: aorta
Atrial Fibrillaton How does the heart work? The heart is the organ responsible for pumping blood to and from all tissues of the body. The heart is divided into right and left sides. The job of the right
More informationLeft-Sided Congestive Heart Failure
Left-Sided Congestive Heart Failure Jessica McGinnis, DVM University of Florida College of Veterinary Medicine Amara Estrada, DVM, DACVIM (Cardiology) University of Florida College of Veterinary Medicine
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationor it may be from dramatically increased
VETTALK Volume 15, Number 05 American College of Veterinary Pharmacists MANAGEMENT OF CARDIOVASCULAR DISEASE Introduction As awareness of cardiovascular disease increases in human medicine, there is now
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
More informationMorphological Investigations of the Anterior Leaflet and its Chordae Tendineae in Canine Mitral Valves
Morphological Investigations of the Anterior Leaflet and its Chordae Tendineae in Canine Mitral Valves Takuma Aoki Yoko Fujii Hiroshi Sunahara Keisuke Sugimoto Yoshito Wakao Laboratory of Veterinary Surgery
More informationARRHYTHMIAS IN THE INTENSIVE CARE UNIT
ARRHYTHMIAS IN THE INTENSIVE CARE UNIT Nicole Van Israël, DVM, CESOpht, CertSAM, CertVC, DECVIM-CA (Cardiology), MSc, MRCVS European Specialist in Veterinary Cardiology Animal CardioPulmonary Consultancy
More informationUSA Product Label VETMEDIN CHEWABLE TABLETS. Boehringer Ingelheim. (pimobendan) NADA , Approved by FDA. Cardiac drug for oral use in dogs only
USA Product Label http://www.vetdepot.com BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002 Telephone: 800-325-9167 Fax: 816-236-2717 Website: www.bevaccinesmart.com
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationNOW RACE Certified Earn CE Credits for Lunch and Learns
In this Issue COVER Recommendations on the Management of Incidentally Detected Heart Murmurs Page 2 Page 5 New Cardiologist 4 Days a Week For Veterinarian Section New Handouts For Tech Section Locations
More information